{
  "paper_metadata": {
    "pmid": "36525500",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the KCNH2 gene variant R531W, including clinical significance, penetrance data, and functional studies."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.C1591T",
      "protein_notation": "p.Arg531Trp",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 3,
        "demographics": "not specified",
        "phenotype": "Long QT syndrome type 2 (LQTS2)"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 1,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 33.33,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Clone 4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "LQTS2",
          "evidence_sentence": "Of the edited KCNH2R531W hiPSC clones, clone 4 was used for all further experiments."
        },
        {
          "individual_id": "Clone 2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "1 of 12 viable clones had the target heterozygous edit (deemed clone 4), while 2 of 17 viable clones had the target heterozygous edit in the second round (deemed clones 2 and 9)."
        },
        {
          "individual_id": "Clone 9",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "1 of 12 viable clones had the target heterozygous edit (deemed clone 4), while 2 of 17 viable clones had the target heterozygous edit in the second round (deemed clones 2 and 9)."
        }
      ],
      "functional_data": {
        "summary": "The R531W mutation in KCNH2 leads to a significant decrease in IKr current density, indicating a detrimental effect on hERG function.",
        "assays": [
          "whole-cell patch-clamp electrophysiology",
          "Western blotting for hERG1a",
          "calcium transient measurements"
        ]
      },
      "segregation_data": "The variant segregates with disease in the edited hiPSC lines.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study utilized CRISPR-Cas9 gene editing to create the R531W mutation in KCNH2.",
      "key_quotes": [
        "R531 is among these important amino acids within the VSD and has been suggested to have a number of functions, including gating charge movement and inactivation.",
        "Edited hiPSC-CM IKr current density was found to be significantly decreased, indicative that the impact of R531W mutation is detrimental to hERG function."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the KCNH2 variant R531W was successfully extracted."
  }
}